Besides overexpression of FcγRIIB on target cells and effector cells in the TME [25, 26], increased levels of MMPs are also reported for B‐cell lymphoma [27, 28, 29, 30, 31]. This evidence concerns the gene FCGR2B and B-cell non-Hodgkin lymphoma.